Latest News About - Vesicular stomatitis

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Tuesday, January 19, 2021

8:55:00 AM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Bruno Pitard ajoute: "qui est surtout intéressant avec ces vaccins ADN et ARN, c’est qu’au-delà [de la production] des anticorps (IgG et IgM), ils permettent également une réponse immunitaire cellulaire" External link

francetvinfo Saturday, January 16, 2021 11:49:00 AM CET

Roger M Perlmutter said: “Building upon the promising clinical findings to date for MK-7110, Merck is pleased to be collaborating with the U.S. Government to advance the manufacture and distribution of this candidate for patients with serious COVID-19 disease,” External link

4-traders Wednesday, December 23, 2020 12:48:00 PM CET

Stephen Russell says: “It is intrinsically happier in cancer cells than in normal cells,” External link

nature-current Wednesday, November 25, 2020 3:38:00 PM CET

Stephen Russell says: “Stacy is now beyond seven years, and she’s still doing great,” External link

nature-current Wednesday, November 25, 2020 3:38:00 PM CET

Stephen Russell says: “We did see tumour regressions in other patients, but never complete and never durable,” “It’s been very difficult to reproduce, and obviously it’s been frustrating to us. We puzzled over what was special about Stacy” External link

nature-current Wednesday, November 25, 2020 3:38:00 PM CET

Don Morris says: “It’s the drug that keeps on giving,” External link

nature-current Wednesday, November 25, 2020 3:38:00 PM CET

Roger M Perlmutter said: “Meaningful new therapeutic options are desperately needed for possibly millions of people around the world who will develop severe or critical COVID-19 disease,” External link

4-traders Monday, November 23, 2020 12:54:00 PM CET

Yang Liu said: “Outstanding work by the OncoImmune team has provided compelling evidence regarding the use of CD24Fc in patients with severe and critical COVID-19 in our Phase 3 Trial,” External link

4-traders Monday, November 23, 2020 12:54:00 PM CET

Kim Reynolds said: “No one wants to do this. I don’t want to do this,” External link

globalbiodefense Monday, November 23, 2020 2:25:00 AM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.